This is a Validated Antibody Database (VAD) review about human TARC, based on 2 published articles (read how Labome selects the articles), using TARC antibody in all methods. It is aimed to help Labome visitors find the most suited TARC antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
TARC synonym: A-152E5.3; ABCD-2; SCYA17; TARC; C-C motif chemokine 17; CC chemokine TARC; T cell-directed CC chemokine; chemokine (C-C motif) ligand 17; small inducible cytokine subfamily A (Cys-Cys), member 17; small-inducible cytokine A17; thymus and activation-regulated chemokine

Abcam
rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 4c
Abcam TARC antibody (Abcam, ab182793) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 4c). Nat Commun (2018) ncbi
rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig s1a
  • flow cytometry; human; loading ...; fig s2
In order to assess the use of anti-CCR4 antibody in a mouse model of renal cell carcinoma, Abcam TARC antibody (Abcam, ab182793) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig s1a) and in flow cytometry on human samples (fig s2). J Clin Invest (2017) ncbi
Articles Reviewed
  1. GarcĂ­a Nores G, Ly C, Cuzzone D, Kataru R, Hespe G, Torrisi J, et al. CD4+ T cells are activated in regional lymph nodes and migrate to skin to initiate lymphedema. Nat Commun. 2018;9:1970 pubmed publisher
  2. Berlato C, Khan M, Schioppa T, Thompson R, Maniati E, Montfort A, et al. A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer. J Clin Invest. 2017;127:801-813 pubmed publisher